Old Web
English
Sign In
Acemap
>
Paper
>
Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
2020
Giorgio Zauli
Veronica Tisato
Paola Secchiero
Keywords:
Intensive care medicine
Pharmacology
IDASANUTLIN
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Diabetes mellitus
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
20
References
2
Citations
NaN
KQI
[]